Alzheimer's Disease Research Center

$40,029P50FY2018AGNIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Paper 39677464 Paper 39666240 Paper 39444005 Paper 39402379 Paper 39402332 Paper 39379761 Paper 39371140 Paper 39345521 Paper 39254167 Paper 39234651 Paper 39231932 Paper 39207439 Paper 39173101 Paper 38980643 Paper 38958543 Paper 38958117 Paper 38949538 Paper 38942763 Paper 38903124 Paper 38883718 Paper 38848188 Paper 38747387 Paper 38721926 Paper 38712163 Paper 38641585 Paper 38460116 Paper 38441951 Paper 38425303 Paper 38423160 Paper 38418871 Paper 38244935 Paper 38244079 Paper 38215191 Paper 38194584 Paper 38014121 Paper 37762325 Paper 37745545 Paper 37606973 Paper 37605362 Paper 37592813 Paper 37580727 Paper 37578203 Paper 37563872 Paper 37547016 Paper 37528055 Paper 37491248 Paper 37338127 Paper 37322115 Paper 37292975 Paper 37292694 Paper 37260021 Paper 37248328 Paper 37245492 Paper 37212114 Paper 37141452 Paper 37125552 Paper 37057867 Paper 37051669 Paper 37038809 Paper 36997127 Paper 36970907 Paper 36946449 Paper 36840665 Paper 36758620 Paper 36722399 Paper 36710669 Paper 36692179 Paper 36681388 Paper 36648159 Paper 36641671 Paper 36628434 Paper 36621368 Paper 36617779 Paper 36577280 Paper 36565204 Paper 36564192 Paper 36530083 Paper 36524738 Paper 36482861 Paper 36453775 Paper 36450991 Paper 36394443 Paper 36324086 Paper 36314203 Paper 36308307 Paper 36289000 Paper 36264254 Paper 36253382 Paper 36251929 Paper 36223053 Paper 36220593 Paper 36189595 Paper 36178120 Paper 36164936 Paper 36099407 Paper 36097795 Paper 36093697 Paper 36062452 Paper 36031904 Paper 36031892

Abstract

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a major global public health threat for which we have very limited responses. Solutions will come only though research. The AD Centers (ADC) Program is a leading effort by the US under the responsibility of the National Institute on Aging (NIA) to develop solutions for AD. The central research strategy of NIA is Seeking the Earliest Interventions. The University of Washington (UW) ADC is one of fifteen AD Research Centers (ADRCs), and we contribute uniquely to this premier program through our vision of precision medicine for AD: comprehensive classification of an individual's risk; surveillance with accurate and early detection of patho-physiologic processes while still preclinical; and interventions tailored to an individual's molecular drivers of disease All components of UW ADRC are focused on this vision and our 5-year mission of creating the knowledge and tools needed to advance preclinical biomarkers and develop experimental therapeutics, while also enthusiastically participating in (inter)national collaborations in clinicl trials, AD genetics, brain aging, diagnostics, and outreach to disparities populations. UW ADRC balances stability with innovation. Stability in the leadership of our required Cores assures highest quality outcomes for the ADC Program. Innovation draws on the vast resources of UW to develop three new Projects, a new Satellite Core, and a new component of our Clinical Core to fuel discoveries. UW ADRC resonates strongly with the three principles of National Plan to Address Alzheimer's Disease, especially its third: transform the way we approach AD. Successful completion of our 5-year mission will hasten this transformation to the right intervention for the right person at the right time - precision medicine for AD.

View original record on NIH RePORTER →